Baader Bank Aktiengesellschaft Sells 4,565 Shares of Teleflex Incorporated $TFX

Baader Bank Aktiengesellschaft reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 10.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,768 shares of the medical technology company’s stock after selling 4,565 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Teleflex were worth $4,634,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Banque Cantonale Vaudoise raised its position in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. V Square Quantitative Management LLC acquired a new position in Teleflex during the 4th quarter worth approximately $37,000. UMB Bank n.a. grew its stake in shares of Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares in the last quarter. Sound Income Strategies LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at approximately $45,000. Finally, Kestra Advisory Services LLC acquired a new position in Teleflex during the fourth quarter worth $45,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Performance

Shares of TFX opened at $134.33 on Tuesday. The firm has a 50-day moving average of $130.57 and a 200-day moving average of $120.56. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The company has a market cap of $5.95 billion, a PE ratio of -5.89, a price-to-earnings-growth ratio of 1.00 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the prior year, the firm earned $1.44 EPS. Teleflex’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were paid a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

Wall Street Analyst Weigh In

TFX has been the topic of several recent research reports. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $140.00 to $160.00 in a research note on Monday, June 8th. Raymond James Financial restated an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research report on Saturday, June 27th. BMO Capital Markets initiated coverage on Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target for the company. Finally, Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $135.00 to $155.00 in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $148.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.